XtalPi secures $15m to boost AI drug development and design offering
XtalPi is advancing artificial intelligence models and prediction-driven research capabilities to improve drug design and small molecule development services.
Archives for January 25, 2018
Eurofins adds radiolabelling service with CRO acquisition
Eurofins Scientific has incorporated radiolabelling services and boosted drug discovery capabilities to following the acquisition of UK CRO Selcia.
Avista Pharma: Solid Form Solutions purchase complements service offering, scales footprint
Avista Pharma Solutions, Inc. has acquired Solid Form Solutions, Ltd. to provide customers with a broader suite of services as a single company, says CEO.
Sanofi signs with IONTAS to discover antibodies using mammalian display tech
Sanofi and IONTAS have signed an agreement through which the company will use IONTAS’ proprietary technology – which aims to bridge the gap between a “great lead” and “poor developability,” says CBO.
Analgesics and beyond: Time-release delivery firm looks for investment
InSitu Biologics says it is looking for investors to support its hydrogel-based drug delivery system AnestaGel.
Shortages and soaring generic prices prompt US hospitals to form not-for-profit drug business
Drug shortages and rising medicine prices in the US have driven a group of hospitals to form a not-for-profit generic drug manufacturing firm.
US FDA gets heavy on ‘unscrupulous’ opioid addiction product sellers
The US FDA has issued warning letters to eleven companies for marketing unapproved products claiming to treat opioid addiction and withdrawal.